首页> 外文期刊>Parkinsonism & related disorders >Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials
【24h】

Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials

机译:基于阿特拉斯的MRI体积的亨廷顿病中脑萎缩分数:临床试验的样本量计算

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: A volumetric MRI analysis of longitudinal regional cerebral atrophy in Huntington's disease (HD) was performed as a read-out of disease progression to calculate sample sizes for future clinical trials.
机译:介绍:亨廷顿疾病(HD)纵向区域脑萎缩的体积MRI分析作为疾病进展的读出,以计算未来临床试验的样本尺寸。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号